[34] Julius, M., Lang, C.A., Gleiberman, L., Harburg, E., Difranceisco, W
Min Wu, [email protected] This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Appetite suppressants often create conflicts between performance nutrition needs and artificially dampened hunger signals, potentially compromising recovery, muscle preservation, and energy availability
Primary ECs, in turn, are sourced either from animal tissues or patient biopsies and offer the possibility of comparing a diseased phenotype and a dysfunctional status to control cells [79, 80]